
Laurus Labs


Working at Laurus Labs
Company Summary
Overall Rating

8% above

Highly rated for 
Job security, Company culture, Salary
Work Policy




Top Employees Benefits
About Laurus Labs

Laurus Labs is a global leader in APIs & FDF. Our position was strengthened by our backward-integration capability while remaining highly regulatory compliant across all operations.
We emerged as one of the most trusted and largest pharmaceutical Contract Development & Manufacturing Organizations (CDMO) in India for both generics and the proprietary space.
While small-molecule chemistry is ingrained in our DNA, Laurus Labs recognizes the potential and differential benefits of large molecules, namely biologicals and biotechnology products, in the healthcare and nutritional space. We permeated this domain with the inception of Laurus Bio and continue the commitment by investing and collaborating in Cell and Gene therapies.
Laurus Labs Ratings
Overall Rating
Category Ratings
Job security
Company culture
Salary
Work-life balance
Skill development
Work satisfaction
Promotions
Work Policy at Laurus Labs
Laurus Labs Reviews
Top mentions in Laurus Labs Reviews
Compare Laurus Labs with Similar Companies
![]() | ![]() Change Company | ![]() Change Company | ![]() Change Company | |
---|---|---|---|---|
Overall Rating | 4.2/5 based on 1.7k reviews | 3.7/5 based on 1.4k reviews | 4.0/5 based on 5.8k reviews ![]() | 5.0/5 based on 1 reviews |
Highly Rated for | Job security Work-life balance Salary | Job security | Salary Skill development Job security | Skill development Work-life balance Salary |
Critically Rated for | ![]() No critically rated category | Promotions Work satisfaction Company culture | ![]() No critically rated category | ![]() No critically rated category |
Primary Work Policy | Work from office 89% employees reported | Work from office 90% employees reported | Work from office 82% employees reported | - |
Rating by Women Employees | 4.2 Good rated by 134 women | 3.9 Good rated by 155 women | 4.0 Good rated by 442 women | - no rating available |
Rating by Men Employees | 4.2 Good rated by 1.5k men | 3.7 Good rated by 1.1k men | 4.0 Good rated by 5k men | - no rating available |
Job security | 4.2 Good | 4.0 Good | 3.8 Good | 4.0 Good |
Laurus Labs Salaries
Associate 4
Associate 3
Associate2
Chemist
Associate 5
Associate L2
Research Associate
Production Chemist
Executive Level 2
Deputy Manager
Laurus Labs Interview Questions
Interview questions by designation
Top Laurus Labs interview questions and answers
Laurus Labs Jobs
Laurus Labs News
Stocks that will see action today: March 7, 2025
- Aarti Drugs received an Administrative Warning letter from SEBI for violation of Insider Trading Regulations, 2015.
- K&R Rail Engineering secured an order from Indian Port Rail and Ropeway Corporation Limited for projects ranging from Rs 50 to 5000 crore.
- IIFL Facilities Services purchased additional shares of Avanti Feeds for Rs 470 crore.
- NCLAT issued a notice to Ambuja Cements over a plea by Alok Sanghi regarding insolvency proceedings.
- Coromandel International opened a new sulphur manufacturing plant in Andhra Pradesh to double its capacity.
- BEL received additional orders worth ₹577 crore, bringing its total order book for FY25 to over ₹13,000 crore.
- Jay Bharat Maruti increased its shareholding in JBM OGIHARA Die-Tech to 49% by acquiring equity stake.
- KPIL secured new orders worth Rs 2,306 crore, increasing its total order book to Rs 22,500 crore.
- Laurus Labs approved investment of Rs 83.30 crore in joint venture KRKA Pharma for setting up a new manufacturing facility.
- Biocon Biologics collaborated with Civica Inc. to supply Insulin Aspart drug substance for enhancing access and affordability in the US.

Bandu’s Blockbusters for January 26, 2025
- Bandu is an avid investor and trader who selects five stocks each week that he believes will be blockbusters.
- This week, Bandu's stock picks are Britannia Industries, UltraTech Cement, Laurus Labs, DCM Shriram, and Eicher Motors.
- Bandu is running a contest where participants have to guess the stock that will give the best return by next Friday.
- The winner of the contest will receive a prize of ₹2,000, and the deadline to submit entries is this Wednesday noon.

The Fifth Episode of Crafting Bharat: Deep Tech with Fermbox Bio
- India's bioeconomy has witnessed a surge from US$10 billion in 2014 to over US$130 billion in 2024.
- Fermbox Bio is pioneering precision fermentation as India's tech ecosystem flourishes.
- Fermbox Bio is building a million-litre fermentation facility in Thailand in partnership with BBGI.
- Fermbox Bio's goal is to disrupt global fermentation by focusing on collaboration and scalability.
- Nithish Kumar from Speciale Invest interviews Fermbox Bio's Subramani Ramachandrappa in this episode.
- They discuss the complexities of the biotech sector and what precision fermentation means.
- Fermbox Bio makes enzymes free of animal derivatives to make vaccines safer.
- Subramani Ramachandrappa left Biocon to start his entrepreneurial journey with Richcore.
- Richcore was later acquired by Laurus Labs, paving the way for the establishment of Fermbox Bio.
- Subramani Ramachandrappa believes biotech's future will lie in openness and partnerships.

Stocks To Buy Today: Dr Reddy's, BHEL HCC, Aurobindo Pharma And More
- Analysts have shared 'buy' calls on BHEL, HCC, Dr Reddy's, Aurobindo Pharma, IPCA Labs, and Laurus Labs.
- Some of these companies could see upside of as much as 9% in the near term from current levels.
- Top stocks to buy, as recommended by experts: Dr Reddy's Laboratories, Aurobindo Pharma, Laurus Labs, HCC, IPCA Laboratories.
- Stocks like Dr Reddy's and Aurobindo Pharma have shown significant gains in the past 12 months.

Laurus Labs Offices
Compare Laurus Labs with




















Contribute & help others!
Companies Similar to Laurus Labs












Laurus Labs FAQs
Reviews
Interviews
Salaries
Users/Month